Table 3.
Intervention has no effect on mortality | Intervention promotes survival in patients with robust or high cognition | Intervention sustains patients who are less healthy or have poor cognition | ||||||
---|---|---|---|---|---|---|---|---|
Treatment improves cognition among always survivors | No | Yes | No | Yes | No | Yes | ||
Scenario | 1 | 2 | 3 | 4 | 5 | 6 | ||
Always survivors | 38% | 38% | 38% | 38% | 38% | 38% | ||
Mortality benefiters | 0% | 0% | 21% | 21% | 21% | 21% | ||
Always diers | 62% | 62% | 41% | 41% | 41% | 41% | ||
Treatment effects: | ||||||||
Survivors analysis | 0 | 15 | 0 | 15 | -7 | 2 | ||
Survivor average causal effect | 0 | 15 | 0 | 15 | 0 | 15 | ||
Composite endpoint* | ||||||||
Rank statistic | 0 | 0.12 | 0.36 | 0.55 | 0.29 | 0.41 | ||
Median under intervention | Survive >72 days | Survive >72 days | Survive 12 months with cognition >34 | Survive 12 months with cognition >49 | Survive 12 months with cognition >20 | Survive 12 months with cognition >20 | ||
75th centile under intervention | Survive 12 months with cognition >39 | Survive 12 months with cognition >54 | Survive 12 months with cognition >41 | Survive 12 months with cognition >56 | Survive 12 months with cognition >39 | Survive 12 months with cognition >54 |
For composite endpoint analysis, the median under control is survive >72 days, the 75th centile under control is survive to 12 months with cognition score >39.